Federal department
Patented Medicine Prices Review Board Canada
Patented Medicine Prices Review Board Canada relies more on directed and sole-source awards than the federal norm — only 18.9% of contracts were competitive against a 55.1% government-wide average. Reported spend rose 71% between 2019 and 2025.
At a glance
Patented Medicine Prices Review Board Canada's recorded federal contracting, 2019–2025, from Government of Canada procurement disclosure.
Federal spend (2019–2025)
$5.4M
Contracts
56
Vendors
40
Competitively awarded
18.9%
Median contract
$20,760
Amendment rate
3.6%
Spend by year
2019–2025 federal spend
2019
$94,278
2020
$1.2M
2021
$3.1M
2022
$213,507
2023
$283,342
2024
$435,796
2025
$161,269
Top spending categories
What Patented Medicine Prices Review Board Canada buys
Healthcare, Social Services & Indigenous$3.6M · 5 contracts
IT Services & Consulting$1.0M · 21 contracts
Staffing & Professional Services$217,148 · 9 contracts
Software & Cybersecurity$206,906 · 5 contracts
Education & Research$136,066 · 6 contracts